Q2 2026 Holdings
Filed 2026-08-14 | 18 holdings | $221.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $41.8M | 2,866,138 | 18.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $37.5M | 69,282 | 17.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $30.0M | 524,786 | 13.6% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $20.2M | 370,693 | 9.1% |
| Abbott Laboratories(ABT) | COM | 002824100 | $18.1M | 200,000 | 8.2% |
| Sanofi(SNY) | COM | 80105N105 | $13.8M | 323,946 | 6.3% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $13.1M | 280,681 | 5.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $13.1M | 390,879 | 5.9% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $7.2M | 1,180,388 | 3.3% |
| Biontech SE(BNTX) | COM | 09075V102 | $5.5M | 59,523 | 2.5% |
| GSK PLC(GSK) | COM | 37733W204 | $5.1M | 96,729 | 2.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.3M | 20,000 | 2.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $3.7M | 6,000 | 1.7% |
| Embecta Corp(EMBC) | COM | 29082K105 | $3.7M | 1,135,340 | 1.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.7M | 534,523 | 1.2% |
| Evolus Inc(EOLS) | COM | 30052C107 | $1.1M | 157,985 | 0.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | COM | G50871105 | $40.4K | 167,816 | 0.0% |
| Inmode LTD(INMD) | COM | M5425M103 | $1.8K | 120,942 | 0.0% |